Your browser doesn't support javascript.
loading
The challenge of hypophosphatasia diagnosis in adults: results from the HPP International Working Group Literature Surveillance.
Brandi, Maria Luisa; Khan, Aliya A; Rush, Eric T; Ali, Dalal S; Al-Alwani, Hatim; Almonaei, Khulod; Alsarraf, Farah; Bacrot, Severine; Dahir, Kathryn M; Dandurand, Karel; Deal, Chad; Ferrari, Serge Livio; Giusti, Francesca; Guyatt, Gordon; Hatcher, Erin; Ing, Steven W; Javaid, Muhammad Kassim; Khan, Sarah; Kocijan, Roland; Lewiecki, E Michael; Linglart, Agnes; M'Hiri, Iman; Marini, Francesca; Nunes, Mark E; Rockman-Greenberg, Cheryl; Seefried, Lothar; Simmons, Jill H; Starling, Susan R; Ward, Leanne M; Yao, Liang; Brignardello-Petersen, Romina; Roux, Christian.
Afiliación
  • Brandi ML; F.I.R.M.O. Italian Foundation for the Research On Bone Diseases, Florence, Italy. marialuisa.brandi@unifi.it.
  • Khan AA; Donatello Bone Clinic, Villa Donatello Hospital, Florence, Italy. marialuisa.brandi@unifi.it.
  • Rush ET; Division of Endocrinology and Metabolism, McMaster University, Hamilton, Canada.
  • Ali DS; Division of Clinical Genetics, Children's Mercy Kansas City and Department of Pediatrics, University of Missouri-Kansas City School of Medicine, Kansas City, MO, USA.
  • Al-Alwani H; Division of Endocrinology, Metabolism, Osteoporosis, and Genetics, Department of Internal Medicine, University of Kansas School of Medicine, Kansas City, KS, USA.
  • Almonaei K; Division of Endocrinology and Metabolism, McMaster University, Hamilton, Canada.
  • Alsarraf F; Division of Endocrinology and Metabolism, McMaster University, Hamilton, Canada.
  • Bacrot S; Division of Endocrinology and Metabolism, McMaster University, Hamilton, Canada.
  • Dahir KM; Division of Endocrinology and Metabolism, McMaster University, Hamilton, Canada.
  • Dandurand K; Department of Genetics, Centre Hospitalier de Versailles, Hôpital André Mignot, Versailles, France.
  • Deal C; Division of Endocrinology and Metabolism, Vanderbilt University Medical Center, Nashville, TN, USA.
  • Ferrari SL; Department of Medicine, Endocrinology and Metabolism, Université de Sherbrooke, Sherbrooke, QC, Canada.
  • Giusti F; Center for Osteoporosis and Metabolic Bone Disease, Department of Rheumatology, The Cleveland Clinic Foundation, Cleveland, OH, USA.
  • Guyatt G; Division of Bone Diseases, Department of Internal Medicine Specialties, Geneva University Hospitals and Faculty of Medicine, Geneva, Switzerland.
  • Hatcher E; Donatello Bone Clinic, Villa Donatello Hospital, Florence, Italy.
  • Ing SW; Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, ON, Canada.
  • Javaid MK; Neuromuscular Clinic, McMaster University Medical Centre, Hamilton Health Sciences, Hamilton, ON, Canada.
  • Khan S; Division of Endocrinology, Diabetes, & Metabolism, Ohio State University Wexner Medical Center, Columbus, OH, USA.
  • Kocijan R; Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK.
  • Lewiecki EM; Bone Research and Education Centre, Oakville, ON, Canada.
  • Linglart A; Trauma Centre Meidling, Ludwig Boltzmann Institute of Osteology at Hanusch Hospital of OEGK and AUVA, 1St Medical Department Hanusch Hospital, 1140, Vienna, Austria.
  • M'Hiri I; New Mexico Clinical Research & Osteoporosis Center, Albuquerque, NM, USA.
  • Marini F; APHP, Bicêtre Paris-Sud, University Paris Sud, Paris-Saclay, Le Kremlin Bicêtre, Paris, France.
  • Nunes ME; Bone Research and Education Centre, Oakville, ON, Canada.
  • Rockman-Greenberg C; F.I.R.M.O. Italian Foundation for the Research On Bone Diseases, Florence, Italy.
  • Seefried L; Division of Medical Genetics and Metabolism, Valley Children's HealthCare, Madera, CA, USA.
  • Simmons JH; Department of Pediatrics and Child Health, University of Manitoba, Winnipeg, MB, Canada.
  • Starling SR; Musculoskeletal Center Würzburg, University of Würzburg, Würzburg, Germany.
  • Ward LM; Division of Endocrinology and Metabolism, Vanderbilt University Medical Center, Nashville, TN, USA.
  • Yao L; Division of Clinical Genetics, Children's Mercy Kansas City and Department of Pediatrics, University of Missouri-Kansas City School of Medicine, Kansas City, MO, USA.
  • Brignardello-Petersen R; Department of Pediatrics, Children's Hospital of Eastern Ontario, University of Ottawa, Ottawa, ON, Canada.
  • Roux C; Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, ON, Canada.
Osteoporos Int ; 35(3): 439-449, 2024 Mar.
Article en En | MEDLINE | ID: mdl-37982856
ABSTRACT
Hypophosphatasia (HPP) is an inborn error of metabolism caused by reduced or absent activity of the tissue non-specific alkaline phosphatase (TNSALP) enzyme, resulting from pathogenic variants in the ALPL gene. Clinical presentation of HPP is highly variable, including lethal and severe forms in neonates and infants, a benign perinatal form, mild forms manifesting in adulthood, and odonto-HPP. Diagnosis of HPP remains a challenge in adults, as signs and symptoms may be mild and non-specific. Disease presentation varies widely; there are no universal signs or symptoms, and the disease often remains underdiagnosed or misdiagnosed, particularly by clinicians who are not familiar with this rare disorder. The absence of diagnosis or a delayed diagnosis may prevent optimal management for patients with this condition. Formal guidelines for the diagnosis of adults with HPP do not exist, complicating efforts for consistent diagnosis. To address this issue, the HPP International Working Group selected 119 papers that explicitly address the diagnosis of HPP in adults through a Medline, Medline In-Process, and Embase search for the terms "hypophosphatasia" and "HPP," and evaluated the pooled prevalence of 17 diagnostic characteristics, initially selected by a group of HPP clinical experts, in eligible studies and in patients included in these studies. Six diagnostic findings showed a pooled prevalence value over 50% and were considered for inclusion as major diagnostic criteria. Based on these results and according to discussion and consideration among members of the Working Group, we finally defined four major diagnostic criteria and five minor diagnostic criteria for HPP in adults. Authors suggested the integrated use of the identified major and minor diagnostic criteria, which either includes two major criteria, or one major criterion and two minor criteria, for the diagnosis of HPP in adults.
Asunto(s)
Palabras clave

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Hipofosfatasia Límite: Adult / Humans / Infant / Newborn Idioma: En Revista: Osteoporos Int Asunto de la revista: METABOLISMO / ORTOPEDIA Año: 2024 Tipo del documento: Article País de afiliación: Italia

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Hipofosfatasia Límite: Adult / Humans / Infant / Newborn Idioma: En Revista: Osteoporos Int Asunto de la revista: METABOLISMO / ORTOPEDIA Año: 2024 Tipo del documento: Article País de afiliación: Italia